Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective
Tài liệu tham khảo
Abu-Id, 2008, “Bis-phossy jaws” – high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J. Craniomaxillofac. Surg., 36, 95, 10.1016/j.jcms.2007.06.008
Advisory Task Force on Bisphosphonate-Related Osteoencrosis of the Jaws, 2007, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws, J. Oral Maxillofac. Surg., 65, 369, 10.1016/j.joms.2006.11.003
Aguirre, 2010, Effects of alendronate on bone healing after tooth extraction in rats, Oral Dis., 16, 674, 10.1111/j.1601-0825.2010.01677.x
Allen, 2011, The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing, Odontology, 99, 8, 10.1007/s10266-010-0153-0
Aragon-Ching, 2009, Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents, Cancer Investig., 27, 221, 10.1080/07357900802208608
Bagan, 2013, Bisphosphonates-related osteonecrosis of the jaws: a preliminary study of salivary interleukins, J. Oral Pathol. Med., 42, 405, 10.1111/jop.12021
Bakker, 2009, Tumor necrosis factor α and interleukin-1β modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes, Arthritis Rheum., 60, 3336, 10.1002/art.24920
Bala, 2012, Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization, J. Bone Miner. Res., 27, 825, 10.1002/jbmr.1501
Bivi, 2012, Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation, J. Bone Miner. Res., 27, 374, 10.1002/jbmr.548
Bonewald, 2011, The amazing osteocyte, J. Bone Miner. Res., 26, 229, 10.1002/jbmr.320
Bonewald, 2008, Osteocytes, mechanosensing and Wnt signaling, Bone, 42, 606, 10.1016/j.bone.2007.12.224
Donetti, 2014, Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa, Oral Dis., 20, 466, 10.1111/odi.12154
Drake, 2008, Bisphosphonates: mechanism of action and role in clinical practice, Mayo Clin. Proc., 83, 1032, 10.4065/83.9.1032
Duncan, 1995, Mechanotransduction and the functional response of bone to mechanical strain, Calcif. Tissue Int., 57, 344, 10.1007/BF00302070
Endo, 2017, Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ), Biol. Pharm. Bull., 40, 739, 10.1248/bpb.b16-01020
Epari, 2010, Mechanobiology of bone healing and regeneration: in vivo models, Proc. Inst. Mech. Eng. H, 224, 1543, 10.1243/09544119JEIM808
Feller, 2009, The nature of fibrous dysplasia, Head Face Med, 5, 10.1186/1746-160X-5-22
Fliefel, 2015, Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review, Int. J. Oral Maxillofac. Surg., 44, 568, 10.1016/j.ijom.2015.01.026
Florencio-Silva, 2015, Biology of bone tissue: structure, function, and factors that influence bone cells, Biomed. Res. Int., 2015, 10.1155/2015/421746
Fukuda, 2013, Sema3A regulates bone-mass accrual through sensory innervations, Nature, 497, 490, 10.1038/nature12115
Galvão, 2011, Optimization of the tartrate-resistant acid phosphatase detection by histochemical method, Eur. J. Histochem., 55, 10.4081/ejh.2011.e1
Gong, 2011, Bisphosphonates pathway, Pharmacogenet. Genomics, 21, 50, 10.1097/FPC.0b013e328335729c
Gong, 2017, Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro BMSCs osteogenic activity, Sci. Rep., 7
Graves, 2011, Inflammation and uncoupling as mechanisms of periodontal bone loss, J. Dent. Res., 90, 143, 10.1177/0022034510385236
Hansson, 2012, Alveolar ridge resorption after tooth extraction: a consequence of a fundamental principle of bone physiology, J. Dent. Biomech., 3, 10.1177/1758736012456543
Haugh, 2015, The role of integrin αVβ3 in osteocyte mechanotransduction, J. Mech. Behav. Biomed. Mater., 42, 67, 10.1016/j.jmbbm.2014.11.001
He, 2004, LDL receptor-related proteins 5 and 6 in Wnt/b-catenin signaling: arrows point the way, Development, 131, 1663, 10.1242/dev.01117
Hesse, 2014, Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron μCT study, PLoS One, 9, 10.1371/journal.pone.0088481
Heymann, 2010, Bisphosphonates and bone diseases: past, present and future, Curr. Pharm. Des., 16, 2948, 10.2174/138161210793563572
Hikita, 2009, Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats, J. Bone Miner. Res., 27, 663, 10.1007/s00774-009-0090-6
Howie, 2015, A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma, PLoS One, 10, 10.1371/journal.pone.0132520
Huang, 2010, Mechanotransduction in bone repair and regeneration, FASEB J., 24, 3625, 10.1096/fj.10-157370
Ikebe, 2013, Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw, Oral Sci. Int., 10, 1, 10.1016/S1348-8643(12)00045-6
Jacobs, 2015, Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts, Clin Oral Investig, 19, 699, 10.1007/s00784-014-1284-4
Jobke, 2014, Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients, Bone, 59, 37, 10.1016/j.bone.2013.10.024
Kim, 2016, Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw, Clin Oral Investig, 20, 2251, 10.1007/s00784-016-1718-2
Krishnan, 2006, Regulation of bone mass by Wnt signaling, J. Clin. Invest., 116, 1202, 10.1172/JCI28551
Landesberg, 2011, Potential pathophysiological mechanisms in osteonecrosis of the jaw, Ann. N. Y. Acad. Sci., 1218, 62, 10.1111/j.1749-6632.2010.05835.x
Lesclous, 2009, Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?, Bone, 45, 843, 10.1016/j.bone.2009.07.011
MacGregor, 1979, An apparatus for measuring the forces of dental extraction, Br. J. Oral Surg., 17, 71, 10.1016/0007-117X(79)90010-6
Manzano-Moreno, 2015, High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis, J. Craniomaxillofac. Surg., 43, 396, 10.1016/j.jcms.2014.12.008
Marie, 2014, Integrin and cadherin signaling in bone: role and potential therapeutic targets, Trends Endocrinol. Metab., 25, 567, 10.1016/j.tem.2014.06.009
Masi, 2007, Calcitonin and calcitonin receptors, Clin. Cases Miner. Bone Metab., 4, 117
Matsumoto, 2013, Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization, J. Bone Miner. Res., 28, 1191, 10.1002/jbmr.1844
Matsuo, 2012, Bone cell interactions through Eph/ephrin bone modeling, remodeling and associated diseases, Cell Adhes. Migr., 6, 148, 10.4161/cam.20888
Migliorati, 2013, Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction, J. Am. Dent. Assoc., 144, 406, 10.14219/jada.archive.2013.0134
Negishi-Koga, 2011, Suppression of bone formation by osteoclastic expression of semaphorin 4D, Nat. Med., 17, 1473, 10.1038/nm.2489
Otto, 2012, Bisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatment, J. Craniomaxillofac. Surg., 40, 303, 10.1016/j.jcms.2011.05.003
Otto, 2017, Further development of the MRONJ minipig large animal model, J. Craniomaxillofac. Surg., 45, 1503, 10.1016/j.jcms.2017.07.002
Pathak, 2016, Systemic inflammation affects human osteocyte-specific protein and cytokine expression, Calcif. Tissue Int., 98, 596, 10.1007/s00223-016-0116-8
Pazianas, 2014, Bisphosphonates and bone quality, Bonekey Rep., 3
Plotkin, 2013, Beyond gap junctions: Connexin43 and bone cell signaling, Bone, 52, 157, 10.1016/j.bone.2012.09.030
Plotkin, 2008, Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo, J. Bone Miner. Res., 23, 1712, 10.1359/jbmr.080617
Qaisi, 2016, Denosumab related osteonecrosis of the jaw with spontaneous necrosis of the soft palate: report of a life threatening case, Case Rep. Dent., 2016, 5070187
Qing, 2012, Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation, J. Bone Miner. Res., 27, 1018, 10.1002/jbmr.1567
Roelofs, 2010, Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo, J. Bone Miner. Res., 25, 606, 10.1359/jbmr.091009
Ruggiero, 2014, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update, J. Oral Maxillofac. Surg., 72, 1938, 10.1016/j.joms.2014.04.031
Russell, 2011, Bisphosphonates: the first 40 years, Bone, 49, 2, 10.1016/j.bone.2011.04.022
Saia, 2010, Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction, J. Oral Maxillofac. Surg., 68, 797, 10.1016/j.joms.2009.10.026
Sharma, 2013, Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect, Vasc. Cell, 5, 1, 10.1186/2045-824X-5-1
Stenbeck, 2002, Formation and function of the ruffled border in osteoclasts, Semin. Cell Dev. Biol., 13, 285, 10.1016/S1084952102000587
Sutton, 2008, Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice, J. Mol. Endocrinol., 22, 1370, 10.1210/me.2007-0363
Temiyasathit, 2010, The osteocyte primary cilium and its role in bone mechanotransduction, Ann. N. Y. Acad. Sci., 1192, 422, 10.1111/j.1749-6632.2009.05243.x
Teti, 1991, Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity, Am. J. Phys., 261, C1, 10.1152/ajpcell.1991.261.1.C1
Tolstunov, 2012, Odontogenic osteomyelitis or bisphosphonate-related osteonecrosis of mandible of patient with autoimmune disease: clinical dilemma, Compend. Contin. Educ. Dent., 33
Turner, 1998, Mechanotransduction and functional response of the skeleton to physical stress: the mechanisms and mechanics of bone adaptation, J. Orthop. Sci., 3, 346, 10.1007/s007760050064
Vidal-Gutiérrez, 2017, Dental extraction following zoledronate, induces osteonecrosis in rat's jaw, Med. Oral Patol. Oral Cir. Bucal., 22, e177
Viviano, 2017, A rare case of osteonecrosis of the jaw related to imatinib, J. Korean Assoc. Oral Maxillofac. Surg., 43, 120, 10.5125/jkaoms.2017.43.2.120
Wang, 2014, Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model, Arthritis Rheumatol., 66, 107, 10.1002/art.38195
Watabe, 2011, Mechanotransduction activates α5β1 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts, Exp. Cell Res., 317, 2642, 10.1016/j.yexcr.2011.07.015
Zafar, 2016, Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts, Clin Oral Investig, 10.1007/s00784-015-1706-y
Zara, 2015, Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts, Clin Oral Investig, 19, 601, 10.1007/s00784-014-1280-8
Zhao, 2011, Bidirectional ephrinB2-ephB4 signaling controls bone homeostasis, Cell Metab., 4, 111, 10.1016/j.cmet.2006.05.012